MET’s near-term price action is weak: it is down 3.20% over 24 hours at $0.299254, and trades closer to the $0.29509 low than the $0.308254 high. It sits about 32% of the way up the day’s range from its low, consistent with pressure persisting through the session rather than a recovery toward the high.

The hourly moving averages reinforce that cautious short-term picture. Price is below the 8, 13, 21, and 55-hour averages by roughly 0.15% to 0.38%, and is 3.14% below the 144-hour average, with the larger gap indicating the clearest overhead moving-average hurdle among those supplied.

Momentum readings are subdued rather than strongly directional. The 1-hour RSI of 49 is near neutral, while the 7-day RSI of 46 is below the neutral midpoint and aligns with recent weakness, but neither reading alone indicates an extreme condition.

Returns across different periods conflict. MET is down 9.48% over seven days, while it remains up 18.99% over 14 days and 61.14% over 30 days, suggesting that the recent pullback has not erased the gains over the longer periods shown.

That conflict argues against treating the short-term weakness as conclusive evidence of a broader reversal, but also against relying on the monthly gain as a reason to buy immediately. The data show a strong positive 30-day return alongside a negative weekly return and price below every supplied hourly moving average; the shorter-horizon weakness is more directly relevant to current entry conditions.

Trading volume is 9,401,634, with volume equal to 5.63% of market capitalization. Without comparable historical volume data, this figure cannot establish whether participation is increasing or unusually high, so it offers limited confirmation of either a rebound or further selling.

MET is also about 56% below its listed all-time high of $0.686913. This establishes substantial distance from that peak, but the supplied figures do not show how price has behaved since the high or identify a level at which buyers have consistently stepped in.

Overall rating: Hold. The 14- and 30-day gains provide meaningful evidence against a Sell rating, while the negative weekly and daily changes, price near the lower end of its daily range, and position below all listed hourly moving averages weaken the case for a Buy.

The primary evidence supporting Hold is this split: the broader reported returns remain positive, but the immediate price and moving-average signals are bearish to neutral. The near-neutral RSI readings do not resolve that conflict, and the supplied volume data provide no comparative trend confirmation.